PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study defines criteria for MET-driven lung cancer suitable for crizotinib treatment

2015-09-08
(Press-News.org) Many cancers include increased copies of the gene MET. But in which cases is MET driving the cancer and in which do these increased copies happen to "ride along" with other molecular abnormalities that are the true cause of the disease? The answer influences whether a tumor will respond to drugs that inhibit MET, like crizotinib. A University of Colorado Cancer Center study being presented today at the 16th World Conference on Lung Cancer in Denver, Colorado sheds light on the best method to determine the threshold at which MET amplification becomes clinically relevant.

"Generally, there are two ways that the number of copies of the MET gene can be increased: The tumor can make multiple copies of the entire chromosome on which it sits - chromosome 7 - or it can amplify just the MET region. In the first case, MET is unlikely to be the specific driver of the cancer's biology, it may just be a ride along. But if the MET region is amplified separate from the rest of the chromosome, this would suggest that the MET gene is indeed the area of specific importance to the cancer," says Sinead Noonan, MD, investigator at the CU Cancer Center, senior thoracic oncology fellow at the CU School of Medicine, and the study's first author.

The goal of the current study was to find evidence supporting the above hypothesis and to identify a group of MET-driven patients in which crizotinib would be effective.

To do so, Noonan worked with Marileila Garcia, PhD, CU Cancer Center investigator and professor of Oncology at the CU School of Medicine, who assessed the genetics of over 1,000 lung cancer patients. Using the low level criteria commonly used for defining an increase in MET copy number, independent of whether it was increased by increasing the overall number of copies of the chromosome or just that region of the chromosome, 14.4 percent of these samples were positive for MET copy number gain. The group then looked at another measure, comparing MET copy number to the number of chromosome 7 centromeres - the center point of the chromosome - which allowed them to see how specifically MET was amplified in comparison with the chromosome as a whole. When the low level criteria for defining an increase in MET copy number using the ratio of MET to centromere 7 was used, only 4.5 percent of these cases were positive.

Now the question was what ratio of MET to centromere 7, exactly, defined patients whose tumors were driven by this gene amplification and so would be most susceptible to MET inhibition via crizotinib.

"There is almost always only one driver abnormality in any given tumor," Noonan says. But in 47 percent of the tumors defined by the minimal MET-to-centromere-7 ratio criteria, the group was able to identify other known genetic drivers, including mutations or gene rearrangements in EGFR, KRAS, BRAF, ALK, ERBB2, RET or ROS1.

"Strikingly, as we looked at cases with higher and higher MET positivity, the degree of overlap with other known drivers decreased," Noonan says. In other words, as the MET-to-centromere-7 ratio increased, the group was less likely to find any other candidates for the cause of the cancer.

A group completely free from overlap with other known cancer drivers was only found in the group in which MET overbalanced centromere 7 by 5 times. Using the other common method of simply counting MET, independent of the ratio, it was impossible to find a group without additional known genetic driver.

"I think these data really help to solidify MET-to-centromere ratio as the better measure for defining a lung cancer driven by MET copy number," says D. Ross Camidge, MD, PhD, Joyce Zeff Chair in Lung Cancer Research at the CU Cancer Center and the senior author of the study. "While the highest ratio only occurs in 0.34 percent of cases, it has clearly been associated with responses to crizotinib approaching 70 percent. However, responses have also been seen at lower ratios. Overall, if we look across all levels of MET-ratio positive cases but exclude those with other identifiable drivers we can identify a group representing 2.4 percent of adenocarcinomas which is ripe for further investigation as potential MET-sensitive subtypes of lung cancer."

The drug company Pfizer has an ongoing clinical trial program to evaluate the usefulness of crizotinib against a range of drivers, including MET copy number-driven lung cancer. The drug has already been shown to be useful against lung cancer driven by ALK and ROS1 gene rearrangements.

"There's definitely a population of patients with cancers sensitive to MET inhibition that can be identified by MET copy number increase. The challenge is finding these people accurately so they can get the best, most personalized approach to treatment possible," says Noonan.

INFORMATION:



ELSE PRESS RELEASES FROM THIS DATE:

Flu vaccine reduces hospitalizations and deaths among nursing home residents

2015-09-08
When the influenza vaccine is well matched to the prevailing strains of flu in a given season, patients in nursing homes are significantly less likely to be hospitalized or to die of pneumonia and other influenza related causes. The finding comes from a study of more than 1 million Medicare fee-for-service long-stay nursing home residents. When the vaccine's match with A/H3N2--the influenza strain typically responsible for severe symptoms--was excellent (75%) during an A/H3N2 predominant season, there was an estimated 2.0% reduction in deaths and a 4.2% reduction in ...

Personalized medicine's success needs accurate classification of tumors

2015-09-08
DENVER, Colo. - If cancer patients are to receive optimal treatment, clinicians must have an accurate histologic classification of the tumor and know its genetic characteristics, said William D. Travis, M.D., attending thoracic pathologist, Department of Pathology, at Memorial Sloan Kettering Cancer Center in New York City. Dr. Travis made his remarks today at the 16th World Conference on Lung Cancer (WCLC) hosted by the International Association of the Study of Lung Cancer (IASLC). Dr. Travis said the pathology and oncology professions made a big step towards this goal ...

Study's findings could help expand the donor pool for liver transplantation

2015-09-08
Organ donation after circulatory death (DCD), in which transplant organs are taken from donors after ay period of no blood circulation or oxygenation, is often considered inferior to donation after brain death, in which circulation and oxygenation are maintained until organs are removed for transplantation. Currently, the use of livers from DCD donors remains controversial, particularly with donors with advanced age. A new study of DCD liver transplantations conducted at the Cleveland Clinic from 2005 to 2014 found no significant correlation between donor age and organ ...

Many childhood brain tumor survivors experience seizures

2015-09-08
New research reveals that seizures are frequent in childhood brain tumor survivors. Among 298 children who were diagnosed with a brain tumor at least 2 years earlier and were followed for an average of 7.6 years, 24% of patients experienced seizures at the start of the study and 14% continued to experience them on an ongoing basis. Certain factors such as the type of tumor, its location, and the extent of surgery predispose patients to ongoing seizures. "This information will allow clinicians to understand better who needs to stay on antiseizure medications and who ...

Exposure to wildfire smoke linked to increased ER visits for asthma

2015-09-08
Researchers who analyzed data from the 2006-2007 wildfires in Australia found that exposure to wildfire smoke was linked to increased visits to hospital emergency departments for asthma. The findings reveal the adverse health impacts due to wildfire particulate pollution in communities. These fine particulates are harmful because they are easily inhaled and remain present deep in the lungs. "Given the increase in frequency and intensity of wildfires experienced worldwide in recent years, it's important to understand the impact of wildfire smoke exposure on acute health ...

Experts examine ways to address anemia and blood loss in surgery patients

2015-09-08
Anemia is common, and in surgical patients can increase various risks associated with operations. While blood transfusion can be a lifesaver for patients in these situations, it may not be always be appropriate and can even increase risks. A new review presents a 'patient blood management' program to help clinicians make decisions relating to anemia and blood transfusion. The approach relies on 3 pillars of care: detecting and treating anemia before surgery, reducing blood loss during surgery, and optimizing management of anemia after surgery. The program can be used ...

Study identifies psychological traits associated with homophobia

2015-09-08
A new study that investigated the potential of certain psychological traits for predisposing heterosexuals to have negative attitudes towards homosexual people found that psychoticism--which is present in severe psychopathological conditions but may also contribute to less severe states of hostility and anger--and immature defense mechanisms may be important risk factors for homophobia, while depression and neurotic defense mechanisms appear to lower the risk of being homophobic. "After discussing for centuries if homosexuality is to be considered a disease, for the first ...

Infant learning: Is more really better?

2015-09-08
Many parents and caregivers believe that multi-sensory stimulation during infancy promotes developmental growth and learning, but researchers who conducted eye movement experiments on preverbal infants show that this is not always true. The team discovered that 8 to 10 month old infants could learn basic abstract rules, such as sequences, but only when the audio and visual stimuli were "congruently" or "consistently" paired. If a smiling face was paired with a crying sound, the infants were confused, and they did not learn the rule. The findings indicate that having ...

New rule to help identify fractures in young children with head trauma

2015-09-08
A new decision rule will help emergency department physicians determine when to use radiography in young children with minor head injuries. The Canadian-developed rule is published in CMAJ. Head injury is a common reason for children to visit emergency departments, resulting in more than 20 000 visits in Canada and 470 000 in the United States each year. Although termed "minor," these head injuries may have complications such as skull fractures and brain injury. Computed tomography (CT) scans, which are the most effective diagnostic tool, carry an increased risk of cancer, ...

Psychedelic therapy re-emerging for anxiety, PTSD and addiction

2015-09-08
Renewed medical interest in the use of psychedelic drugs for anxiety, posttraumatic stress disorder (PTSD) and addiction has resulted in small research studies that show some success with the controlled use of these drugs, according to an analysis published in CMAJ (Canadian Medical Association Journal). Psychedelic drugs are substances that have a strong effect on one's "conscious experience," such as lysergic acid diethylamide (LSD), psilocybin, found in "magic mushrooms," dimethyltryptamine (DMT), mescaline and methylenedioxymethamphetamine (MDMA). "The re-emerging ...

LAST 30 PRESS RELEASES:

Doctors received approximately $12.1 billion from drug and device makers between 2013-2022

Discovery suggests new strategy against follicular lymphoma

Making the future too bright: how wishful thinking can point us in the wrong direction

Ochsner Health named to Newsweek’s America’s Greatest Workplaces 2024 for Job Starters

Three-year study of young stars with NASA’s Hubble enters new chapter

North Carolina takes the lead in PFAs research with Collaboratory’s $3 million investment to expand the state’s research capacity

Is it the school, or the students?

Exploring the relationship between HIV pre-exposure prophylaxis and the incidence of chlamydia, gonorrhea and syphilis – findings from Denmark

Music: Song lyrics have become simpler and more repetitive since 1980

Environment: More than half of Colorado River’s water used to irrigate crops

When inequality is more than “skin-deep”: Social status leaves traces in the epigenome of spotted hyenas in Tanzania

Study explores the future of at-home cancer treatment

First performance standards published to measure the effectiveness of lifestyle medicine treatments

To keep volunteers, connect them

Suppressing boredom at work hurts future productivity, study shows

Older brain cells linger unexpectedly before their death

Clear shift in arterial diseases in diabetes

Celebrating half a century of pioneering excellence: EBMT marks its 50th anniversary

Ancient DNA reveals the appearance of a 6th century Chinese emperor

DNA study IDs descendants of George Washington from unmarked remains, findings to aid service member IDs going back to World War II

Familial Alzheimer’s disease transferred via bone marrow transplant in mice

Perspectives of oncologists on the ethical implications of using AI for cancer care

Industry payments to US physicians by specialty and product type

Andrew E. Place, MD, PhD appointed as Dana-Farber/Boston Children’s Cancer and Blood Disorders Center Vice President, Pediatric Chief Medical Officer

COVID-19 antibody discovery could explain long COVID

Wild plants face viral surprise

Storing electrons from hydrogen for clean chemical reactions

Unlocking how to use mRNA to target Alzheimer’s disease

Kessler Foundation secures $770,000 in grants to advance leading-edge spinal cord research

Going ‘back to the future’ to forecast the fate of a dead Florida coral reef

[Press-News.org] Study defines criteria for MET-driven lung cancer suitable for crizotinib treatment